Harvard Heart Letter

Heart Beat: Generic ARBs are coming

The FDA has approved the sale of a generic version of the angiotensin-receptor blocker medication losartan, and generic versions of two other ARBs may soon follow.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »